Figure 4.

Efficacy of passive immunotherapy of influenza H5N1 virus infection by i.p. injection of F(ab')2 at dose of 50, 100 and 200 μg/mouse at 24 h after intranasal challenge with the influenza Guangdong H5N1 virus strain.

Lu et al. Respiratory Research 2006 7:43   doi:10.1186/1465-9921-7-43
Download authors' original image